In blood therapy, Hyland introduced Hemofil antohemophilic factor, a revolutionary product for the treatment of hemophilia. 1971 Baxter joins Fortune magazine's listing of the 500 largest American corporations. The company moves into its current corporate headquarters in Deerfield, Illinois. THE 1980s Vernon R. Loucks Jr. becomes president and chief executive officer, succeeding William B. Graham. Baxter introduced the HomeChoice dialysis machine, a compact, user-friendly device that cleanses the patient's blood overnight.
New plant opens in Singapore to manufacture peritoneal-dialysis solutions for the Asian market.
Baxter opens a plant in China to manufacture peritoneal-dialysis solutions for the Chinese market. Baxter announces plans to open two more plants in China, these to manufacture IV solutions. Baxter renews its focus on its core technologies of renal technology, biotechnology, cardiovascular medicine and medication delivery, and increases its emphasis on global expansion. Baxter receives clearance from the U.S. Food and Drug Administration for its new Colleague volumetric infusion pump, which is designed to provide accurate, cost-effective infusion for a broad range of therapies. Baxter acquires more than 50 percent of Immuno International AG , a leading manufacturer of biological products and plasma derivatives.